Two Sigma Investments, LP Talaris Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$2.68 - $3.22 $52,568 - $63,160	19,615 Added 8.66%	246,030 $691,000
Q2 2023 Aug 14, 2023	BUY	$1.78 - $3.2 $353,954 - $636,323	198,851 Added 721.42%	226,415 $688,000
Q1 2023 May 15, 2023	SELL	$1.09 - $2.09 $84,047 - $161,155	-77,108 Reduced 73.67%	27,564 $51,000
Q4 2022 Feb 14, 2023	BUY	$0.94 - $1.64 $65,324 - $113,970	69,494 Added 197.55%	104,672 $106,000
Q3 2022 Nov 14, 2022	BUY	$2.3 - $5.03 $80,909 - $176,945	35,178 New	35,178 $93,000
Q4 2021 Feb 14, 2022	SELL	$12.18 - $17.0 $131,495 - $183,532	-10,796 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$11.61 - $15.99 $396,725 - $546,394	-34,171 Reduced 75.99%	10,796 $146,000
Q2 2021 Aug 16, 2021	BUY	$12.25 - $18.61 $550,845 - $836,835	44,967 New	44,967 $661,000

75.7K

Ticker TALS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,995,900
Market Cap $109M
Description
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.